Michelle Lockley

Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer

Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer

Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study

Data from The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma

Data from The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma

The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma

Addressing the diagnostic and therapeutic dilemmas of ovarian immature teratoma: Report from a clinicopathologic consensus conference

The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in<i>BRCA1</i>and<i>BRCA2</i>

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study

Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data

Correction: Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma—experience of the BriTROC consortium

Copy number signatures and mutational processes in ovarian carcinoma

Ovarian cancer in adolescents and young adults

Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers

Copy-number signatures and mutational processes in ovarian carcinoma

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma—experience of the BriTROC consortium

Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control

Direct histological processing of EUS biopsies enables rapid molecular biomarker analysis for interventional pancreatic cancer trials